Apollo Hospitals Enterprise is currently trading at Rs. 7390.80, up by 13.40 points or 0.18% from its previous closing of Rs. 7377.40 on the BSE.

The scrip opened at Rs. 7394.95 and has touched a high and low of Rs. 7484.20 and Rs. 7361.90 respectively. So far 13231 shares were traded on the counter.

The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 7634.45 on 08-Jul-2025 and a 52 week low of Rs. 6002.15 on 03-Mar-2025.

Last one week high and low of the scrip stood at Rs. 7484.20 and Rs. 7220.00 respectively. The current market cap of the company is Rs. 106688.22 crore.

The promoters holding in the company stood at 29.34%, while Institutions and Non-Institutions held 65.06% and 5.61% respectively.

Apollo Hospitals Enterprise and Siemens Healthineers have joined hands for a research collaboration to advance innovation in liver healthcare. The research, spanning quantitative ultrasound imaging to AI-driven clinical solutions, aims to enhance liver disease management by improving patient care pathways and outcomes from early detection and risk stratification to monitoring intervention and therapy response. AI-driven disease progression models shall play a pivotal role in early detection of fibrosis, allowing timely interventions, cost-effective screening, and improved patient outcomes.

Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, etc.

Bhupendra singh chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur kiranhis insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.